With both mitigation of aggressive inflammatory cytokines in the PPs and the spleen after A. argyi treatment, we detected significant increases in IL-10 gene expression in both tissues, suggesting the possibility that A. argyi reinforces immunomodulatory effects in IBD pathogenesis, with the activation of IL-10 importance to the mechanism. This evidence concerns the gene IL10 and inflammatory bowel disease.